Endocrine Complications of Cystic Fibrosis

Abstract

Endocrine comorbidities have become increasingly important medical considerations as improving cystic fibrosis (CF) care increases life expectancy. Although the underlying pathophysiology of CF-related diabetes remains elusive, the use of novel technologies and therapeutics seeks to improve both CF-related outcomes and quality of life. Improvements in the overall health of those with CF have tempered concerns about pubertal delay and short stature; however, other comorbidities such as hypogonadism and bone disease are increasingly recognized. Following the introduction of highly effective modulator therapies there are many lessons to be learned about their long-term impact on endocrine comorbidities.

Keywords: Body composition; Bone accrual; Cystic fibrosis bone disease; Cystic fibrosis-related diabetes; Diabetes management; Diabetes technologies; Dual X-ray absorptiometry; Growth.